Isbn: 9786630284362 - microneedles for cns and brain drug delivery: from exosomes to gene therapy (7 resultados)

ISBN
Refinar con la Búsqueda avanzada

Filtrar la búsqueda

  • Libros (7)

  • Nuevo (7)

a

Intervalo de precios personalizado (EUR)

a

  • Idioma: Inglés

    Editorial: LAP Lambert Academic Publishing, 2026

    6630284364 / 9786630284362

    • Tapa blanda

    Librería: California Books, Miami, FL, Estados Unidos de AmericaCalifornia Books

    Vendedor de 4 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 59,24

     Gastos de envío gratis 
    Se envía dentro de Estados Unidos de America

    Cantidad disponible: Más de 20 disponibles

    Condición: New.

  • Idioma: Inglés

    Editorial: LAP LAMBERT Academic Publishing, 2026

    6630284364 / 9786630284362

    • Tapa blanda

    Librería: PBShop.store UK, Fairford, GLOS, Reino UnidoPBShop.store UK

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 57,33

    Envío por EUR 3,83 
    Se envía de Reino Unido a Estados Unidos de America

    Cantidad disponible: Más de 20 disponibles

    PAP. Condición: New. New Book. Shipped from UK. Established seller since 2000.

  • Idioma: Inglés

    Editorial: LAP Lambert Academic Publishing, 2026

    6630284364 / 9786630284362

    • Tapa blanda
    • Impresión bajo demanda

    Librería: Grand Eagle Retail, Bensenville, IL, Estados Unidos de AmericaGrand Eagle Retail

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 59,55

     Gastos de envío gratis 
    Se envía dentro de Estados Unidos de America

    Cantidad disponible: 1 disponibles

    Paperback. Condición: new. Paperback. The delivery of therapeutics to the Central Nervous System (CNS) and brain remains one of the biggest challenges in pharmaceutics due to the presence of the Blood-Brain Barrier (BBB). Conventional routes often fail to achieve therapeutic concentrations in brain tissue while causing systemic side effects. Microneedle technology has emerged as a minimally invasive, patient-friendly platform that enables direct and targeted drug delivery across biological barriers. By bypassing the BBB through transdermal, intranasal, or direct CNS routes, microneedles can enhance drug bioavailability and localization. Recent advances have expanded the scope of microneedles from delivering small molecules to complex biologics. Integration with next-generation carriers such as exosomes for targeted delivery, and gene therapy vectors like CRISPR-Cas and mRNA, is revolutionizing CNS treatment. This convergence allows for precision therapy in neurodegenerative diseases, brain tumors, and psychiatric disorders.This chapter discusses the design principles, material advancements, and applications of microneedles for CNS and brain drug delivery. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.

  • Idioma: Inglés

    Editorial: LAP LAMBERT Academic Publishing Jul 2026, 2026

    6630284364 / 9786630284362

    • Tapa blanda
    • Impresión bajo demanda

    Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, AlemaniaBuchWeltWeit Ludwig Meier e.K.

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 48,90

    Envío por EUR 23,00 
    Se envía de Alemania a Estados Unidos de America

    Cantidad disponible: 2 disponibles

    Taschenbuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware 76 pp. Englisch.

  • Idioma: Inglés

    Editorial: LAP Lambert Academic Publishing, 2026

    6630284364 / 9786630284362

    • Tapa blanda
    • Impresión bajo demanda

    Librería: CitiRetail, Stevenage, Reino UnidoCitiRetail

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 62,92

    Envío por EUR 43,06 
    Se envía de Reino Unido a Estados Unidos de America

    Cantidad disponible: 1 disponibles

    Paperback. Condición: new. Paperback. The delivery of therapeutics to the Central Nervous System (CNS) and brain remains one of the biggest challenges in pharmaceutics due to the presence of the Blood-Brain Barrier (BBB). Conventional routes often fail to achieve therapeutic concentrations in brain tissue while causing systemic side effects. Microneedle technology has emerged as a minimally invasive, patient-friendly platform that enables direct and targeted drug delivery across biological barriers. By bypassing the BBB through transdermal, intranasal, or direct CNS routes, microneedles can enhance drug bioavailability and localization. Recent advances have expanded the scope of microneedles from delivering small molecules to complex biologics. Integration with next-generation carriers such as exosomes for targeted delivery, and gene therapy vectors like CRISPR-Cas and mRNA, is revolutionizing CNS treatment. This convergence allows for precision therapy in neurodegenerative diseases, brain tumors, and psychiatric disorders.This chapter discusses the design principles, material advancements, and applications of microneedles for CNS and brain drug delivery. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.

  • Idioma: Inglés

    Editorial: LAP LAMBERT Academic Publishing Jul 2026, 2026

    6630284364 / 9786630284362

    • Tapa blanda
    • Impresión bajo demanda

    Librería: buchversandmimpf2000, Emtmannsberg, BAYE, Alemaniabuchversandmimpf2000

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 48,90

    Envío por EUR 60,00 
    Se envía de Alemania a Estados Unidos de America

    Cantidad disponible: 1 disponibles

    Taschenbuch. Condición: Neu. This item is printed on demand - Print on Demand Titel. Neuware -The delivery of therapeutics to the Central Nervous System (CNS) and brain remains one of the biggest challenges in pharmaceutics due to the presence of the Blood-Brain Barrier (BBB). Conventional routes often fail to achieve therapeutic concentrations in brain tissue while causing systemic side effects. Microneedle technology has emerged as a minimally invasive, patient-friendly platform that enables direct and targeted drug delivery across biological barriers. By bypassing the BBB through transdermal, intranasal, or direct CNS routes, microneedles can enhance drug bioavailability and localization. Recent advances have expanded the scope of microneedles from delivering small molecules to complex biologics. Integration with next-generation carriers such as exosomes for targeted delivery, and gene therapy vectors like CRISPR-Cas and mRNA, is revolutionizing CNS treatment. This convergence allows for precision therapy in neurodegenerative diseases, brain tumors, and psychiatric disorders.This chapter discusses the design principles, material advancements, and applications of microneedles for CNS and brain drug delivery. 76 pp. Englisch.

  • Idioma: Inglés

    Editorial: LAP LAMBERT Academic Publishing, 2026

    6630284364 / 9786630284362

    • Tapa blanda
    • Impresión bajo demanda

    Librería: AHA-BUCH GmbH, Einbeck, AlemaniaAHA-BUCH GmbH

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 99,64

    Envío por EUR 30,50 
    Se envía de Alemania a Estados Unidos de America

    Cantidad disponible: 2 disponibles

    Taschenbuch. Condición: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - The delivery of therapeutics to the Central Nervous System (CNS) and brain remains one of the biggest challenges in pharmaceutics due to the presence of the Blood-Brain Barrier (BBB). Conventional routes often fail to achieve therapeutic concentrations in brain tissue while causing systemic side effects. Microneedle technology has emerged as a minimally invasive, patient-friendly platform that enables direct and targeted drug delivery across biological barriers. By bypassing the BBB through transdermal, intranasal, or direct CNS routes, microneedles can enhance drug bioavailability and localization. Recent advances have expanded the scope of microneedles from delivering small molecules to complex biologics. Integration with next-generation carriers such as exosomes for targeted delivery, and gene therapy vectors like CRISPR-Cas and mRNA, is revolutionizing CNS treatment. This convergence allows for precision therapy in neurodegenerative diseases, brain tumors, and psychiatric disorders.This chapter discusses the design principles, material advancements, and applications of microneedles for CNS and brain drug delivery.